A New Drug Shows Promise in Preventing One of the Most Common Causes of Maternal Death

Posted on

By: Kayla McGowan, Project Coordinator, Women and Health Initiative, Harvard T.H. Chan School of Public Health

A large randomized trial conducted by the World Health Organization has found that heat-stable carbetocin is as safe and effective as oxytocin in preventing postpartum hemorrhage—excessive bleeding after childbirth and one of the leading causes of global maternal deaths…read more